AlphaYouBH
Insider selling
Benjamin Halladay sold $34K of Esperion Therapeutics, Inc. (ESPR) stock
Benjamin Halladay, Chief Financial Officer of Esperion Therapeutics, Inc. (ESPR), sold 10,773 shares of ESPR stock worth $34K, per an SEC Form 4 filed Jun 18, 2026.
It was an open-market sale.
The trade happened on Jun 17, 2026, 1 day before it was made public.
- Traded
- Jun 17, 2026
- Disclosed
- Jun 18, 2026
- Filing delay
- 1 day
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More ESPR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.